Related Experiment Video

Updated: Aug 11, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Hepatitis C treatment for people with severe mental illness

Lisa A Mistler1, Mary F Brunette, Bryan J Marsh

  • 1Dartmouth Medical School, Hanover NH, USA. Lisa.A.Mistler@dartmouth.edu

Psychosomatics
|March 2, 2006
PubMed

Insights

Hepatitis C virus (HCV) treatment in individuals with severe mental illness (SMI) is complex due to potential neuropsychiatric side effects of interferon (IFN). This review examines data and offers recommendations for managing HCV in this population.

Area of Science:

  • Hepatology
  • Psychiatry
  • Infectious Diseases

Background:

  • Chronic hepatitis C virus (HCV) infection affects over 4 million Americans, with untreated cases progressing to severe liver disease.
  • Individuals with severe mental illness (SMI) exhibit disproportionately high rates of HCV infection.
  • The management of HCV in patients with SMI is complicated by the potential for neuropsychiatric side effects from antiviral therapies, particularly interferon (IFN).

Purpose of the Study:

  • To review existing data on the neuropsychiatric side effects associated with interferon (IFN) treatment for hepatitis C virus (HCV).
  • To critically evaluate the limitations within the current research concerning HCV treatment in individuals with severe mental illness (SMI).
  • To provide evidence-based recommendations for the effective and safe treatment of HCV in patients with SMI.

Main Methods:

  • Systematic review of published literature on interferon (IFN)-related neuropsychiatric adverse events in hepatitis C virus (HCV) patients.
  • Analysis of studies specifically investigating HCV treatment outcomes and side effects in individuals with severe mental illness (SMI).
  • Synthesis of data to identify patterns, risk factors, and management strategies for neuropsychiatric symptoms during HCV therapy.

Main Results:

  • Interferon (IFN) treatment for hepatitis C virus (HCV) is associated with a range of neuropsychiatric side effects, including depression and anxiety.
  • Patients with severe mental illness (SMI) may be at increased risk for experiencing or exacerbating these side effects.
  • Current research has limitations in fully characterizing the incidence and severity of these side effects in the SMI population.

Conclusions:

  • Hepatitis C virus (HCV) treatment, particularly with interferon (IFN), requires careful consideration of neuropsychiatric risks in individuals with severe mental illness (SMI).
  • Further research is needed to better understand and mitigate these side effects in the SMI population.
  • Personalized treatment approaches and vigilant monitoring are crucial for optimizing HCV treatment outcomes in patients with SMI.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...